- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06582862
The Effect of Aerobic and Anaerobic Exercise on Oxidative Stress and Cellular Fitness in Healthy Trained Young Men
The Effect of Aerobic and Anaerobic Exercise
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Oxidative stress arises from an imbalance between pro-oxidant and antioxidant levels, where the pro-oxidant status, primarily reactive oxygen species (ROS), exceeds the antioxidant defense. This imbalance can damage cellular components such as membranes, lipids, proteins, DNA, and lipoproteins, leading to various chronic and degenerative diseases. The human body defends against oxidative stress through antioxidant mechanisms. Numerous studies have shown that physical exercise increases ROS production, mainly through enhanced activity of phospholipase A2 (PLA2), nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, and xanthine oxidase (XO). If ROS accumulates excessively, it can result in oxidative stress. During anaerobic exercise, lipid peroxidation levels can rise significantly for up to 48 hours post-exercise. The primary sources of free radical production during exercise include the mitochondrial electron transport chain, ischemia-reperfusion injury, and local inflammation, all of which induce oxidative stress.
Acute changes in oxidative stress biomarkers after exercise are often accompanied by an increase in antioxidant response. For instance, levels of uric acid (UA), catalase (CAT), and glutathione peroxidase (GPX) increase after 10 minutes to 4-8 hours of anaerobic exercise. Various types of exercise also stimulate mitochondrial biogenesis, though it remains unclear whether anaerobic or aerobic exercise is more effective in promoting this process in humans. Mitochondria, critical for cellular energy production, generate energy by transferring electrons from food into the respiratory chain system, involving various complex proteins. High-intensity interval training (HIIT) in aerobic exercises like cycling and walking prompts cells to produce more proteins for mitochondria and their ribosomes, effectively counteracting cellular aging. Endurance exercise (low to moderate intensity for 30 to 60 minutes) is well-known to enhance mitochondrial function in skeletal muscle, though the effects of anaerobic exercise on mitochondrial biogenesis are less studied.
Both aerobic and anaerobic exercises positively affect lipid metabolism. Aerobic exercise is particularly effective in improving lipid profiles, notably increasing high-density lipoprotein (HDL). An Australian study showed that aerobic exercise significantly reduced total cholesterol, low-density lipoprotein (LDL), and triglycerides (TG), while increasing HDL by about 0.05 mmol/L. A meta-analysis by Kelley et al. concluded that aerobic exercise increases HDL by 9% and reduces TG by 11%, though it does not significantly alter total cholesterol or LDL levels. Anaerobic exercise has also shown positive effects on lipid profiles. A European study on 16 obese subjects found that combined aerobic and anaerobic training led to a greater reduction in non-esterified fatty acids and body mass index than aerobic training alone.
In summary, physical exercise impacts oxidative stress, mitochondrial function, and metabolic parameters, yet the distinct effects of aerobic versus anaerobic exercise on these factors remain unclear. Aerobic and anaerobic exercises differ primarily in their oxygen (O2) requirements. Aerobic exercises, such as long-distance running, cycling, and jogging, are performed at low to moderate intensity (40% to 70% of VO2max) and rely on oxygen for sustained periods. Anaerobic exercise is performed at high intensity (75% to 100% of VO2 max) and does not rely on oxygen (O2) supply. Examples include sprints of 100 meters or less, throwing sports, and similar activities.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Jakarta
-
Jakarta Pusat, Jakarta, Indonesia, 10430
- Faculty of Medicine Universitas Indonesia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male, aged 18-23.
- body weight of 56-70 kg and a height of 158-175 cm.
- Systolic blood pressure values below 130 mmHg, and diastolic blood pressure below 90 mmHg.
- maximum oxygen consumption (VO2max) is calculated to be greater than 40 mL/(kg-minute).
Exclusion Criteria:
- fever
- having chronic diseases (heart disease, lung disease)
- smoking
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Pre aerobic exercise treatment
Subject will do aerobic exercise 3 times a week for 1 month.
The training program includes the following: Week 1 consists of interval running (2 sets of 10 repetitions of 400 meters each) with 3 minutes of rest between repetitions and 10 minutes of rest between sets.
Week 2 transitions to continuous running for 15-20 minutes.
Week 3 involves 30 minutes of cross-country running.
In Week 4, the program returns to interval running as in Week 1.
|
Subjects will do aerobic and anaerobic exercise
|
|
Experimental: Pre anaerobic exercise treatment
Subject will do anerobic exercise 3 times a week for 1 month.
The sprint training program includes the following: In Weeks 1 and 3, perform sprints of 20 m, 40 m, 60 m, and 80 m, with 2 sets of 5 repetitions each, allowing 5 minutes of rest between repetitions and 10 minutes of rest between sets.
In Weeks 2 and 4, run 2 sets of 5 repetitions of 50 m sprints, with 5 minutes of rest between repetitions and 10 minutes between sets.
|
Subjects will do aerobic and anaerobic exercise
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concentration of Malondialdehyde (MDA)
Time Frame: 1 month
|
MDA in nmoL/mL is measured using spectrophotometer from the subject's plasma
|
1 month
|
|
Concentration of Hydrogen Peroxide
Time Frame: 1 month
|
Hydrogen peroxide in mmol/L is measured using spectrophotometer from the subject's plasma
|
1 month
|
|
Concentration of Superoxide dismutase (SOD)
Time Frame: 1 month
|
SOD in U/mL is measured using spectrophotometer from the subject's plasma
|
1 month
|
|
Concentration of Total Antioxidant Capacity
Time Frame: 1 month
|
Total Antioxidant Capacity in U/mL is measured using spectrophotometer from the subject's plasma
|
1 month
|
|
Concentration of Glutathione Peroxidase (GPx)
Time Frame: 1 month
|
GPx in in U/mL is measured using spectrophotometer from the subject's plasma
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Concentration of Succinate Dehydrogenase (SDH)
Time Frame: 1 month
|
SDH in U/L is measured using spectrophotometer from the peripheral blood mononuclear cells of subject
|
1 month
|
|
Concentration of Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha
Time Frame: 1 month
|
PGC-1alpha in ng/mL is measured using spectrophotometer from the the peripheral blood mononuclear cells of subject
|
1 month
|
|
Concentration of Adenosine triphosphate (ATP)
Time Frame: 1 month
|
ATP in micromole/L is measured using spectrophotometer from the the peripheral blood mononuclear cells of subject
|
1 month
|
|
Concentration of ATPase inhibitor
Time Frame: 1 month
|
ATPase inhibitor in ng/mL is measured using spectrophotometer from the the peripheral blood mononuclear cells of subject
|
1 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Novi Hardiany, Fakultas Kedokteran Universitas Indonesia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 24-05-0791
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health, Subjective
-
University of MiamiNational Heart, Lung, and Blood Institute (NHLBI); WestatRecruiting
-
Chulalongkorn UniversityMae Fah Luang UniversityNot yet recruitingHealth, Subjective
-
Chulalongkorn UniversityNot yet recruiting
-
Prince Sattam Bin Abdulaziz UniversityCompletedHealth, SubjectiveSaudi Arabia
-
Çankırı Karatekin UniversityCompleted
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineCompleted
-
Hebrew SeniorLifeCompletedHealth, Subjective
-
Istanbul University - CerrahpasaRecruiting
-
Bahçeşehir UniversityNot yet recruiting
-
Alteogen, Inc.CompletedHealth, SubjectiveSouth Korea
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University of Missouri-ColumbiaCompleted
-
University of AlcalaCompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point PainSpain
-
University College CorkRecruitingDepressive Disorder, MajorIreland
-
Sahmyook UniversityRecruitingChronic Nonspecific Neck PainKorea, Republic of